Form 4: IMAX CEO Richard Gelfond Executes Stock Option Plan

IMAX CEO Richard Gelfond exercised and sold 120,132 shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• CEO Richard Gelfond exercised stock options for 120,132 common shares across three dates: April 13, 14, and 15, 2026.
• The options were exercised at a strike price of $31.40 per share.
• Following the exercise, the shares were sold at market prices ranging from $37.0678 to $37.1526 per share.
• The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
• Mr. Gelfond maintains a beneficial ownership of 765,002 common shares following these transactions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; it is a routine administrative exercise of equity compensation under a pre-planned schedule.

Positives

• Transactions were conducted under a pre-established 10b5-1 plan, indicating systematic rather than reactive selling.
• The CEO retains a significant equity stake of 765,002 shares, aligning interests with shareholders.

Negatives

• The CEO reduced his immediate holdings of common shares through the sale of the exercised options.

Risks

• The remaining stock options are set to expire on June 7, 2026, creating a time-bound pressure for further exercises or potential forfeiture.

Future Outlook

No specific forward-looking guidance provided; the filing relates to routine executive equity management.

Management Comments

• The transactions were executed pursuant to a 10b5-1 plan dated December 9, 2025.

Industry Context

StockSavvy.ai notes that executive selling via 10b5-1 plans is a standard corporate governance practice used to avoid concerns regarding insider trading, particularly as options approach their expiration dates.

Comparison to Industry Standards

• The use of 10b5-1 plans is the industry standard for C-suite executives to manage equity compensation and liquidity.
• The timing of the exercise is consistent with standard practices for options nearing their 10-year expiration window.

Stakeholder Impact

• Minimal impact on shareholders as the sale was pre-planned and disclosed in accordance with SEC regulations.

Next Steps

• Monitor for further option exercises before the June 7, 2026 expiration date.

Key Dates

Keywords

IMAX, Insider Trading, Form 4, Richard Gelfond, Stock Options, 10b5-1 Plan